Covenant Partners, LLC Charles River Laboratories International, Inc. Transaction History
Covenant Partners, LLC
- $337 Million
- Q3 2024
A detailed history of Covenant Partners, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Covenant Partners, LLC holds 2,587 shares of CRL stock, worth $486,097. This represents 0.15% of its overall portfolio holdings.
Number of Shares
2,587
Previous 2,587
-0.0%
Holding current value
$486,097
Previous $534,000
4.68%
% of portfolio
0.15%
Previous 0.17%
Shares
8 transactions
Others Institutions Holding CRL
# of Institutions
696Shares Held
52.3MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.15 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$956 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.74MShares$703 Million0.13% of portfolio
-
State Street Corp Boston, MA2.13MShares$400 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$364 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.56B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...